Shamburg News · 8-K filed Nov 13, 2026, 5:00 PM EST

Co-Diagnostics Shareholders Approve Plan Amendment, Reverse Split Authority and Financing Proposals

CODX · Co-Diagnostics, Inc.

  • Shareholder vote
  • Other
  • Materiality: medium

On November 13, 2026, Co-Diagnostics, Inc. held a court-ordered special meeting of shareholders at which shareholders approved Amendment No. 1 to the 2025 Equity Incentive Plan, increasing authorized shares by 2,000,000 to a total of 2,223,333. Shareholders also elected five directors to one-year terms, ratified Tanner LLC as auditor for 2026, and approved a reverse stock split authority of not less than 1-for-2 and cumulatively not exceeding 1-for-750, exercisable within twelve months.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 5.02, 5.07, 9.01, accession 0001493152-26-051811.

Written from the filing by Shamburg Markets. Figures are as reported by the company.